DEF 14ACIK 0001712762

bioAffinity Technologies, Inc. (BIAF, BIAFW)

Name: SEC EDGAR filing 0001493152-26-048245
Creator: bioAffinity Technologies, Inc. (BIAF, BIAFW)
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed October 23, 2026.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Open the filing on SEC.gov

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001493152-26-048245
Filer: bioAffinity Technologies, Inc. (BIAF, BIAFW)
CIK: 0001712762
Form type: DEF 14A
Form description: Proxy statement
Filed at: October 23, 2026
Industry: SIC 8731Services — Commercial Physical & Biological Research
Last verified: October 24, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from bioAffinity Technologies, Inc. (BIAF, BIAFW)

See all 44 filings from bioAffinity Technologies, Inc. (BIAF, BIAFW) →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1712762/000149315226048245/0001493152-26-048245-index.htm ↗

Filer's full EDGAR submission history

EDGAR · bioAffinity Technologies, Inc. (BIAF, BIAFW) (0001712762) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001493152-26-048245.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.